Szumilas P, Barcew K, Baśkiewicz-Masiuk M, Wiszniewska B, Ratajczak M Z, Machaliński B
Department of General Pathology, Pomeranian Medical University, Szczecin, Poland.
Cell Prolif. 2005 Feb;38(1):47-61. doi: 10.1111/j.1365-2184.2005.00329.x.
Both granulocyte colony-stimulating factor (G-CSF) and cyclophosphamide (CY) are employed in the clinic as mobilizing agents to stimulate the egress of haematopoietic stem/progenitor cells (HSPC) from bone marrow (BM) into peripheral blood (PB). However, although both compounds are effective, the simultaneous administration of G-CSF + CY allows for optimal mobilization. The aim of this study was to compare morphological changes in major haematopoietic organs in mice mobilized by G-CSF + CY. We employed the standard G-CSF + CY mobilization protocol, in which mice were injected at day 0 with a single dose of CY followed by daily injection of G-CSF for 6 consecutive days. We noticed that the cytoreductive effect of CY on BM and spleen tissue was compensated at day 2 by the pro-proliferative effect of G-CSF. Furthermore, as evidenced by histological examination of BM sections at day 4, egress of haematopoietic cells from BM was accelerated by 2 days as compared to mobilization by G-CSF or CY alone; also, by day 6 there was accumulation of early haematopoietic (Thy-l(low) c-kit+) cells in the spleens and livers of mobilized animals. This implies that HSPC that are mobilized from BM and circulate in PB may 'home' to peripheral organs. We envision that such an accumulation of these cells in the spleen (which is a major haematopoietic organ in mouse) allows them to participate in haematopoietic reconstitution. Their homing to other sites (for example the liver) is evidence that BM-derived stem cells are playing a pivotal role in organ/tissue regeneration. The potential involvement of major chemoattractants for stem cells, like stromal-derived factor-1 which is induced by CY in various regenerating organs such as the liver, requires further study. We conclude that inclusion of CY into mobilization protocols on the one hand efficiently increases the egress of HSPC from the BM, but on the other hand may lead to the relocation of BM stem cell pools to peripheral tissues.
粒细胞集落刺激因子(G-CSF)和环磷酰胺(CY)在临床上均被用作动员剂,以刺激造血干/祖细胞(HSPC)从骨髓(BM)进入外周血(PB)。然而,尽管这两种化合物都有效,但同时给予G-CSF + CY可实现最佳动员效果。本研究的目的是比较由G-CSF + CY动员的小鼠主要造血器官的形态学变化。我们采用了标准的G-CSF + CY动员方案,即小鼠在第0天注射单剂量的CY,随后连续6天每日注射G-CSF。我们注意到,CY对BM和脾脏组织的细胞减少作用在第2天被G-CSF的促增殖作用所补偿。此外,如第4天BM切片的组织学检查所示,与单独使用G-CSF或CY动员相比,造血细胞从BM的流出加速了2天;同样,到第6天,动员动物的脾脏和肝脏中出现了早期造血(Thy-1(low) c-kit+)细胞的积累。这意味着从BM动员并在外周血中循环的HSPC可能“归巢”到外周器官。我们设想,这些细胞在脾脏(小鼠的主要造血器官)中的这种积累使它们能够参与造血重建。它们归巢到其他部位(例如肝脏)证明了BM来源的干细胞在器官/组织再生中发挥着关键作用。干细胞的主要趋化因子(如CY在肝脏等各种再生器官中诱导产生的基质衍生因子-1)的潜在参与需要进一步研究。我们得出结论,一方面,在动员方案中加入CY可有效增加HSPC从BM的流出,但另一方面可能导致BM干细胞池重新定位到外周组织。